Congenital Hypoaldosteronism: The Visser-Cost Syndrome Revisited
Authors:
- 1 March 1996
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 39 (3) , 554-560
Abstract
In 1964, H. K. A. Visser and W. S. Cost were the first to suggest a defect of the terminal aldosterone (Aldo) biosynthesis in patients with hypoaldosteronism. In the last years, the molecular basis of the terminal Aldo biosynthesis has been elucidated. Aldo biosynthesis requires 11β-hydroxylation of 11-deoxycorticosterone to form corticosterone, hydroxylation at position C-18 to form 18-hydroxycorticosterone (18-OHB), and finally oxidation at position C-18. One single cytochrome P450 enzyme(P450aldo) catalyzes all three reactions in the zona glomerulosa. The coding gene is termed CYP11B2. Two inborn errors of terminal Aldo biosynthesis characterized by overproduction of corticosterone and deficient synthesis of Aldo have been described. Corticosterone methyl oxidase deficiency type I (CMO I) is distinguished by decreased production of 18-OHB while CMO II is characterized by overproduction of 18-OHB and an elevated ratio of 18-OHB to Aldo. Both disorders are inherited by an autosomal recessive trait and cause salt-wasting and failure to thrive in early infancy. Our present series includes 14 CMO deficient infants diagnosed by multisteroid analysis (RIA after extraction and automated high performance gel chromatography) which provides precise biochemical criteria for the differentiation of the two CMO variants. So far, three different mutations within the CYP11B2 gene in patients with P450aldo deficiency have been described. Introduction of theses mutations into a CYP11B2 cDNA expression vector construct and subsequent expression in COS cells revealed loss of 11β-hydroxylase, 18-hydroxylase, and 18-dehydrogenase activity of P450aldo. Further molecular studies on more P450aldo-deficient patients might clarify in the future the still existing discrepancies in CYP11B2 (P450aldo) structure-function relationship.Keywords
This publication has 29 references indexed in Scilit:
- Congenitally Defective Aldosterone Biosynthesis in Humans: Inactivation of the P450C18 Gene (CYP11B2) Due to Nucleotide Deletion in CMO I-Deficient PatientsBiochemical and Biophysical Research Communications, 1993
- Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancyEuropean Journal of Pediatrics, 1992
- Congenitally defective aldosterone biosynthesis in humans: The involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patientsBiochemical and Biophysical Research Communications, 1992
- Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studiesEuropean Journal of Pediatrics, 1991
- Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronismBiochemical and Biophysical Research Communications, 1990
- Inborn Error in the Terminal Step of Aldosterone BiosynthesisNew England Journal of Medicine, 1980
- Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisoneThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Salt-losing syndrome in 2 infants with defective 18-dehydrogenation in aldosterone biosynthesis.Archives of Disease in Childhood, 1977
- Hypoaldosteronism in three sibs due to 18-dehydrogenase deficiency.Archives of Disease in Childhood, 1976
- A Reversible Salt-wasting Syndrome of the Newborn and Infant: Possible Infantile HypoaldosteronismArchives of Disease in Childhood, 1963